nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Current perspectives on the benefits of HRT in menopausal women
|
Palacios, S |
|
1999 |
33 |
S1 |
p. 1-13 13 p. |
artikel |
2 |
HRT and cancer risk: separating fact from fiction
|
Schneider, H.P.G |
|
1999 |
33 |
S1 |
p. 65-72 8 p. |
artikel |
3 |
Index
|
|
|
1999 |
33 |
S1 |
p. 89- 1 p. |
artikel |
4 |
Moderation of the daily dose of HRT: benefits for patients
|
Schneider, H.P.G |
|
1999 |
33 |
S1 |
p. 25-29 5 p. |
artikel |
5 |
Moderation of the daily dose of HRT: prevention of osteoporosis
|
Gallagher, J.C |
|
1999 |
33 |
S1 |
p. 57-63 7 p. |
artikel |
6 |
OESCLIM®: an advanced delivery system for HRT
|
Munoz, Alain |
|
1999 |
33 |
S1 |
p. 39-47 9 p. |
artikel |
7 |
OESCLIM®: pre-clinical and clinical profile
|
Guy, M |
|
1999 |
33 |
S1 |
p. 49-55 7 p. |
artikel |
8 |
OESCLIM®: summary of tolerability and safety
|
Brackman, Francois |
|
1999 |
33 |
S1 |
p. 83-88 6 p. |
artikel |
9 |
Optimising delivery systems for HRT
|
Stevenson, J.C |
|
1999 |
33 |
S1 |
p. 31-38 8 p. |
artikel |
10 |
Strategies for effectively addressing women’s concerns about the menopause and HRT
|
Graziottin, A |
|
1999 |
33 |
S1 |
p. 15-23 9 p. |
artikel |
11 |
The long-term tolerability and efficacy of OESCLIM®: results of a 1-year study
|
Taurelle, R |
|
1999 |
33 |
S1 |
p. 73-81 9 p. |
artikel |